L’Oréal’s new Cell BioPrint device analyzes your skin in just 5 minutes

L’Oréal unveils a revolutionary skin analysis device, Cell BioPrint, at CES 2025 that provides detailed biological skin assessments in just five minutes using advanced proteomics technology.

Innovation breakthrough: L’Oréal’s Cell BioPrint represents a significant advancement in personalized skincare by combining proteomics science with miniaturized laboratory technology.

• The credit card-sized device analyzes skin biomarkers to reveal information about skin’s past, present, and future health
• The technology emerged from a partnership between L’Oréal and Korean startup NanoEnTek, leveraging over 100 patents
• The device utilizes microfluidic lab-on-a-chip technology to measure L’Oréal-patented protein biomarkers

Key features and capabilities: Cell BioPrint offers three primary analytical functions that provide unprecedented insights into personal skin health.

• Determines skin’s biological age and provides customized advice for managing aging
• Predicts skin’s responsiveness to active ingredients like retinol
• Forecasts potential cosmetic issues before they become visible, enabling preventative care

Technical process: The device employs a straightforward, non-invasive three-step process for skin analysis.

• Users apply a facial tape strip to their cheek and place it in a buffer solution
• The solution is loaded into a Cell BioPrint cartridge for analysis
• While processing occurs, the companion Skin Connect device captures facial images and users complete a questionnaire

Market context: The launch addresses a significant need in the growing global skincare market, which is projected to reach $125 billion in 2024.

• Nearly 80% of skincare users rely on trial and error to find effective products
• The average consumer tries seven different cleansers before finding one that works
• The technology aims to eliminate guesswork in skincare product selection

Corporate strategy: The Cell BioPrint initiative aligns with L’Oréal’s broader vision of combining beauty expertise with technological innovation.

• L’Oréal maintains 20 research centers with over 4,000 scientists
• The company employs 6,400 tech workers as part of its transformation into a beauty tech leader
• Initial pilot launching in Asia in late 2025

Future implications: While Cell BioPrint represents a significant advancement in personalized skincare analysis, its success will likely depend on consumer adoption and the accuracy of its predictive capabilities. The technology could potentially reshape how consumers approach skincare, moving from reactive treatment to proactive prevention, though real-world validation through the Asian market pilot will be crucial for determining its effectiveness and market viability.